Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In a Phase I/II open-label study of patients with multiple sclerosis and amyotrophic lateral sclerosis, mesenchymal stem cell transplantation was found to be safe and induced an early immunonologic response.

Mesenchymal Stem Cell Transplantation: A Novel Approach to Treating Progressive Neurological Diseases